Mirae Asset Global Investments’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-44,576
Closed -$627K 2225
2024
Q1
$627K Buy
+44,576
New +$646K ﹤0.01% 1799
2023
Q4
Sell
-42,520
Closed -$331K 2581
2023
Q3
$331K Sell
42,520
-2,702
-6% -$29.4K ﹤0.01% 2083
2023
Q2
$646K Sell
45,222
-974
-2% -$13.9K ﹤0.01% 1826
2023
Q1
$676K Sell
46,196
-1,007
-2% -$16.9K ﹤0.01% 1773
2022
Q4
$793K Sell
47,203
-12,913
-21% -$223K ﹤0.01% 1628
2022
Q3
$891K Sell
60,116
-602
-1% -$11.9K ﹤0.01% 1545
2022
Q2
$1.66M Buy
60,718
+10,547
+21% +$313K ﹤0.01% 1203
2022
Q1
$1.89M Sell
50,171
-7,578
-13% -$335K ﹤0.01% 1170
2021
Q4
$3.59M Sell
57,749
-20,411
-26% -$1.55M 0.01% 973
2021
Q3
$6.69M Sell
78,160
-14,992
-16% -$941K 0.02% 759
2021
Q2
$5.77M Sell
93,152
-18,269
-16% -$930K 0.02% 784
2021
Q1
$5.43M Buy
111,421
+23,616
+27% +$1.14M 0.02% 719
2020
Q4
$2.74M Buy
+87,805
New +$2.15M 0.01% 824

Other funds holding OPRX

Mirae Asset Global Investments's OPRX Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of OptimizeRx (OPRX) in Q2 2024, closing a stake of 44,576 shares — an estimated $627K sold.

Mirae Asset Global Investments first reported a position in OPRX in Q4 2020 and held it in 13 quarters. The position peaked at $6.69M in Q3 2021. 92 funds tracked by Wall St. Rank hold OPRX as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining OptimizeRx position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 44,576 OptimizeRx shares in Q2 2024, an estimated $627K.
  • Mirae Asset Global Investments first reported a position in OptimizeRx in Q4 2020 and held it in 13 quarters.
  • Mirae Asset Global Investments's OptimizeRx position peaked at $6.69M in Q3 2021.
  • 92 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.